
James L. Rogers
Examiner (ID: 18465, Phone: (571)270-5374 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644, 1641 |
| Total Applications | 491 |
| Issued Applications | 295 |
| Pending Applications | 0 |
| Abandoned Applications | 199 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19105800
[patent_doc_number] => 11958881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Optimization method for capturing proteins by multi-column continuous chromatography (MCC)
[patent_app_type] => utility
[patent_app_number] => 18/117479
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 6014
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 789
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18117479
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/117479 | Optimization method for capturing proteins by multi-column continuous chromatography (MCC) | Mar 5, 2023 | Issued |
Array
(
[id] => 18278482
[patent_doc_number] => 20230093954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COMPOSITIONS COMPRISING SOLID PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/058306
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058306
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/058306 | Compositions comprising solid particles | Nov 22, 2022 | Issued |
Array
(
[id] => 19181033
[patent_doc_number] => 11987615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Modified immunoglobulins
[patent_app_type] => utility
[patent_app_number] => 17/877612
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 83
[patent_no_of_words] => 40115
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877612
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/877612 | Modified immunoglobulins | Jul 28, 2022 | Issued |
Array
(
[id] => 18330208
[patent_doc_number] => 11635440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Methods of treating based on site-specific tau phosphorylation
[patent_app_type] => utility
[patent_app_number] => 17/843470
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 84
[patent_no_of_words] => 52719
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/843470 | Methods of treating based on site-specific tau phosphorylation | Jun 16, 2022 | Issued |
Array
(
[id] => 17704550
[patent_doc_number] => 20220204556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => SYSTEMS AND METHODS FOR PROCESS SCALE ISOLATION OF IMMUNOGLOBULIN G
[patent_app_type] => utility
[patent_app_number] => 17/560163
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560163 | Systems and methods for process scale isolation of immunoglobulin G | Dec 21, 2021 | Issued |
Array
(
[id] => 17975524
[patent_doc_number] => 11492372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Removal of leaked affinity purification ligand
[patent_app_type] => utility
[patent_app_number] => 17/554865
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12508
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554865 | Removal of leaked affinity purification ligand | Dec 16, 2021 | Issued |
Array
(
[id] => 17514787
[patent_doc_number] => 11293930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
[patent_app_type] => utility
[patent_app_number] => 17/495963
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7145
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/495963 | Method for using light scattering in real time to directly monitor and control impurity removal in purification processes | Oct 6, 2021 | Issued |
Array
(
[id] => 17201400
[patent_doc_number] => 20210341495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHODS OF TREATING BASED ON SITE-SPECIFIC TAU PHOSPHORYLATION
[patent_app_type] => utility
[patent_app_number] => 17/368403
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368403 | Methods of treating based on site-specific tau phosphorylation | Jul 5, 2021 | Issued |
Array
(
[id] => 17214482
[patent_doc_number] => 20210347819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => PROCESS OF MANUFACTURE OF ANNEXIN V
[patent_app_type] => utility
[patent_app_number] => 17/332968
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332968
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332968 | Process of manufacture of annexin V | May 26, 2021 | Issued |
Array
(
[id] => 18575490
[patent_doc_number] => 11732004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Compositions and methods for simplified high efficiency isolation of proteins
[patent_app_type] => utility
[patent_app_number] => 17/225934
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7053
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225934 | Compositions and methods for simplified high efficiency isolation of proteins | Apr 7, 2021 | Issued |
Array
(
[id] => 18064708
[patent_doc_number] => 20220395795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => METHOD FOR EXTRACTING NERVE TISSUE-DERIVED EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/628754
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628754 | Method for extracting nerve tissue-derived exosomes | Jan 14, 2021 | Issued |
Array
(
[id] => 16712231
[patent_doc_number] => 20210079378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
[patent_app_type] => utility
[patent_app_number] => 17/020497
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020497 | Antigen-binding molecule capable of binding two or more antigen molecules repeatedly | Sep 13, 2020 | Issued |
Array
(
[id] => 16712232
[patent_doc_number] => 20210079379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
[patent_app_type] => utility
[patent_app_number] => 17/020543
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020543 | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly | Sep 13, 2020 | Issued |
Array
(
[id] => 17016302
[patent_doc_number] => 11085935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Methods of treating based on site-specific tau phosphorylation
[patent_app_type] => utility
[patent_app_number] => 17/015985
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 85
[patent_no_of_words] => 52802
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/015985 | Methods of treating based on site-specific tau phosphorylation | Sep 8, 2020 | Issued |
Array
(
[id] => 16832156
[patent_doc_number] => 11008397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => De novo binding domain containing polypeptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/817755
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 101
[patent_no_of_words] => 78423
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16817755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/817755 | De novo binding domain containing polypeptides and uses thereof | Mar 12, 2020 | Issued |
Array
(
[id] => 16090449
[patent_doc_number] => 20200199211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
[patent_app_type] => utility
[patent_app_number] => 16/804567
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804567
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804567 | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | Feb 27, 2020 | Issued |
Array
(
[id] => 19090969
[patent_doc_number] => 11952399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Methods for purifying proteins
[patent_app_type] => utility
[patent_app_number] => 16/708987
[patent_app_country] => US
[patent_app_date] => 2019-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 8599
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/708987 | Methods for purifying proteins | Dec 9, 2019 | Issued |
Array
(
[id] => 16312359
[patent_doc_number] => 20200291097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => MULTISTEP FINAL FILTRATION
[patent_app_type] => utility
[patent_app_number] => 16/660635
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660635
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/660635 | Multistep final filtration | Oct 21, 2019 | Issued |
Array
(
[id] => 16012889
[patent_doc_number] => 20200181287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => METHODS OF PURIFYING BISPECIFIC ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/601121
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16601121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/601121 | METHODS OF PURIFYING BISPECIFIC ANTIBODIES | Oct 13, 2019 | Abandoned |
Array
(
[id] => 15866255
[patent_doc_number] => 20200140531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/599482
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16599482
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/599482 | METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS | Oct 10, 2019 | Abandoned |